Premium
P2‐035: Preliminary evaluation of the amyloid PET Radioligand [18F]MK‐3328 in Alzheimer's Disease patients
Author(s) -
SanabriaBohorquez Sandra,
Hostetler Eric,
Van Laere Koen,
Koole Michel,
Bormans Guy,
Serdons Kim,
Hoon Jan,
Vandenberghe Rik,
Versijpt Jan,
De Lepeleire Inge,
Reynders Tom,
Tamagnan Gilles,
Marek Kenneth,
Seibyl John,
Jennings Danna,
Barret Olivier,
Koren Andrei,
Rosen Laura,
Hargreaves Richard,
Evelhoch Jeffrey,
Sur Cyrille,
Forman Mark
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.925
Subject(s) - cerebellum , nuclear medicine , white matter , radioligand , in vivo , cerebellar cortex , standardized uptake value , medicine , chemistry , pathology , positron emission tomography , biology , magnetic resonance imaging , radiology , receptor , microbiology and biotechnology
P2-035 PRELIMINARY EVALUATION OF THE AMYLOID PET RADIOLIGAND [18F]MK-3328 IN ALZHEIMER’S DISEASE PATIENTS Sandra Sanabria-Bohorquez, Eric Hostetler, Koen Van Laere, Michel Koole, Guy Bormans, Kim Serdons, Jan de Hoon, Rik Vandenberghe, Jan Versijpt, Inge De Lepeleire, Tom Reynders, Gilles Tamagnan, Kenneth Marek, John Seibyl, Danna Jennings, Olivier Barret, Andrei Koren, Laura Rosen, Richard Hargreaves, Jeffrey Evelhoch, Cyrille Sur, Mark Forman, Merck, West Point, Pennsylvania, United States; University Hospital Leuven, Leuven, Belgium; UZ Leuven, Leuven, Belgium; KU Leuven, Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium; UZ Brussels, Brussels, Belgium; Merck, Brussels, Belgium; MNI, New Haven, Connecticut, United States; Merck, Upper Gwynedd, Pennsylvania, United States; Merck, West point, Pennsylvania, United States.